Trial Profile
Long term efficacy and safety of Telbivudine and Entecavir in patients with higher viral load chronic hepatitis B without cirrhosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2018
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Telbivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 13 Jul 2018 New trial record